Comprehensive genomic profiling identifies a novel TNKS2–PDGFRA fusion that defines a myeloid neoplasm with eosinophilia that responded dramatically to imatinib therapy

Detalles Bibliográficos
Autores principales: Chalmers, Z R, Ali, S M, Ohgami, R S, Campregher, P V, Frampton, G M, Yelensky, R, Elvin, J A, Palma, N A, Erlich, R, Vergilio, J-A, Chmielecki, J, Ross, J S, Stephens, P J, Hermann, R, Miller, V A, Miles, C R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4349257/
https://www.ncbi.nlm.nih.gov/pubmed/25658984
http://dx.doi.org/10.1038/bcj.2014.95

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4349257/
https://www.ncbi.nlm.nih.gov/pubmed/25658984
http://dx.doi.org/10.1038/bcj.2014.95

Ejemplares similares